3-Nitropropionic Acid-Induced Huntington's Disease in Preclinical Models: Mechanisms, Peripheral Toxicities, Model...

Area of Science:

• Neuroscience
• Biochemistry
• Genetics

Background:

• Huntington's disease (HD) is a neurodegenerative disorder caused by CAG repeat expansion in the huntingtin gene.
• Understanding HD's complex pathophysiology requires robust preclinical models.
• 3-nitropropionic acid (3-NPA) is a widely used agent to induce HD-like pathology in experimental systems.

Purpose of the Study:

• To review the molecular mechanisms of 3-NPA-induced neurotoxicity.
• To assess the relevance of 3-NPA models to Huntington's disease.
• To discuss the limitations and applications of 3-NPA in HD research.

Main Methods:

• Review of scientific literature on 3-NPA and Huntington's disease.
• Analysis of molecular pathways affected by 3-NPA, including mitochondrial function and oxidative stress.
• Evaluation of 3-NPA's ability to recapitulate key HD features.

Main Results:

• 3-NPA inhibits succinate dehydrogenase (SDH), leading to mitochondrial dysfunction and energy failure.
• 3-NPA induces oxidative stress, excitotoxicity, calcium dysregulation, and neuroinflammation, causing striatal neurodegeneration.
• 3-NPA also causes peripheral toxicities, affecting skeletal muscle, kidneys, liver, ovaries, and the heart.

Conclusions:

• 3-NPA is a valuable model for studying HD-related mitochondrial dysfunction and downstream effects.
• Limitations include the lack of mutant huntingtin aggregation and progressive disease course.
• Further research combining metabolic and genetic models is crucial for a comprehensive understanding of HD.